Is RMD stock a Buy, Sell, or Hold?

Based on our analysis, RMD is currently a HOLD with moderate confidence. 📊 HOLD: RMD is fairly valued with market pricing in -0.0% annual growth. Fine to hold or accumulate slowly on dips.

What is the fair value of RMD stock?

Our analysis estimates the fair value range for RMD to be between $219.95 and $229.50. The current price is $230.05.

What is the analyst price target for RMD?

The average Wall Street analyst price target for RMD is $250.22. This implies a potential upside of 8.8% from current levels.

ResMed (RMD) Stock: Buy, Sell, or Hold?

RMD - ResMed Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

$230.05

3.32 (1.46%) ▲

5d: +5.1%

30d: +4.77%

90d: +15.89%

HOLD

MODERATE Confidence

Protect Your RMD Gains

Analysis Updated: Oct 9, 2026 12:00 AM ET

Earnings: Oct 29, 2026 19d

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Oct 7, 2026 at $225.98 · last confirmed Oct 8, 2026

Strength: 5.7/10

Get Alerted When RMD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: RMD is fairly valued with market pricing in -0.0% annual growth. Fine to hold or accumulate slowly on dips.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 8.6%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$313.04

Based on 6.3% avg growth

INTRINSIC VALUE TODAY

$194.38

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.1x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: RMD is currently trading at $230.05, which is considered extended relative to its 30-day fair value range of $219.95 to $229.50. The stock's valuation (Forward PE: 19.0) is in line with its historical norms (19.1). At these levels, the market is pricing in -0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, RMD is in a strong uptrend. The price is approaching resistance at $231.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $219.95 - $229.50

Company Quality Score 56/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.3%

Protect Your Profits

Holding RMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BULLISH: Options cheap (IV 0th percentile)
NEUTRAL: Mixed technical signals (52/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($250.22)
NEUTRAL: Market pricing in -0.0% annual earnings growth - fairly valued
NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation

Trading Range Analysis

30-Day Trading Range $219.95 - $229.50

Current vs Trading Range EXTENDED

Expected Move (7 Days) ±$10.44 (4.5%)

Support & Resistance Levels

Support Level $218.03

Resistance Level $231.36

Current Trend Strong Uptrend

Technical data as of Oct 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) 19.04

Wall Street Target $250.22 (+8.8%)

Revenue Growth (YoY) 8.6%

Earnings Growth (YoY) 2.4%

Profit Margin 27.0%

PE vs Historical 19.0 vs 19.1 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): 0% (market-implied from PE analysis)

1-Year Target $230.05 (0%)

2-Year Target $230.05 (0%)

3-Year Target $230.05 (0%)

3-Yr Target (if PE normalizes) (PE: 19→19) $230.78 (+0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 19.9, Growth: 8.6%) $307.57 (+34%)

Base: (SPY PE: 19.0, Growth: 8.6%) $294.87 (+28%)

Bear: (PE: 16.2, Growth: 8.6%) $250.64 (+9%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (19x PE) as earnings recover.

Trailing PE: 21.74 | Current EPS (TTM): $10.43

Bull Case $288.92 (+26%)

Analyst growth 15.8%, PE expands to 23.9

Base Case $262.66 (+14%)

Market implied 15.8%, PE stable at 21.7

Bear Case $154.18 (-33%)

Severe decline -20.0%, PE contracts to 18.5

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 09, 2026 6:09 PM ET
Data refreshes hourly during market hours. Next update: 7:09 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is RMD showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for RMD.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ALC Alcon AG	STRONG BUY 26 analysts	$84	62 BUY
ISRG Intuitive Surgical Inc	STRONG BUY 32 analysts	$476	39 SELL
RGEN Repligen Corporation	STRONG BUY 22 analysts	$190	39 SELL
WST West Pharmaceutical Serv…	STRONG BUY 17 analysts	$408	51 HOLD
ALGN Align Technology Inc	BUY 16 analysts	$206	62 BUY

ALC Alcon AG

62 BUY

ISRG Intuitive Surgica…

39 SELL

RGEN Repligen Corporat…

39 SELL

WST West Pharmaceutic…

51 HOLD

ALGN Align Technology …

62 BUY

Advanced RMD Option Strategies

Professional options setups generated by AI based on today's RMD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for RMD

RMD Technical Chart RMD Price Prediction RMD Earnings Date RMD Investment Advisor RMD Fair Price Analyzer RMD Options Advisor RMD Options Chain RMD Options Analysis RMD Competitors

Compare RMD with Peers

RMD vs STE
Which one to buy?

RMD vs COO
Which one to buy?

RMD vs MTD
Which one to buy?

RMD vs IDXX
Which one to buy?

RMD vs TFX
Which one to buy?

SINT vs RMD
Winner: RMD

SSKN vs RMD

KRMD vs RMD
Winner: RMD

COO vs RMD

WST vs RMD
Winner: RMD

Create New Comparison View All Competitors

Tradestie